Talking With Docs on MSN
What physicians need patients to understand about cannabidiol products
What physicians need patients to understand about cannabidiol products ...
Jazz Pharmaceuticals JAZZ is best known for its market-leading oxybate franchise, but the company has also carved out a ...
The adult epilepsy market across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and Japan) is poised to grow at a compound annual growth rate (CAGR) of 4.4% from $11.4bn ...
Research suggests cannabis suppresses REM sleep, raising questions about memory, emotion and the purpose of dreams.
Review Article Now Published in the British Journal of Clinical Pharmacology Finds Widely Sold Non-Prescription CBD Products at Doses ...
In the phase 2 LiBBY trial presented, tetrahydrocannabinol and cannabidiol reduced agitation scores and improved clinician-rated outcomes in patients with advanced dementia.
Hemp beverages won over consumers in record time. Now Big Alcohol and Mitch McConnell, in his last act in Congress, are ...
A UConn chemist aims to use hemp-derived CBD in high-performance plastics for medical devices and electronics.
The third and final suspect involved in the burglary in Hull has pleaded guilty. Jesse Van Leeuwen was facing the following ...
Texas will ban delta-8, delta-10, THCP and other hemp products July 31. Here's what remains legal after the Supreme Court ...
White House backs bill to keep hemp THC products legal, GOP sponsor says (Newsletter: July 23, 2026)
Marijuana & insurance coverage bill filed in Senate; KY medical cannabis in hospitals; Study: Marijuana reduces opioid use ...
11don MSN
Cannabis-derived treatment eases agitation in hospice-eligible dementia patients, trial finds
In a first-of-its-kind clinical trial, U.S. researchers found that people with agitation and dementia in late life who took a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results